Between 2019 and 2022, the number of prescriptions dispensed annually through IOPs increased from 64 million to 85 million at a compounded annual growth rate of 10%.
Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.